“Whether the Court can sidestep the district court’s erroneous holding that the Noerr-Pennington doctrine immunizes patent acquisitions from antitrust scrutiny by creating novel exceptions to settled Fourth Circuit collateral-estoppel law that the Fourth Circuit has never adopted.”
